Dr. Pooyan Rohani, MD

Dr. Rohani practices at Mcguiness Dermatology in Plano, Texas.

Dr. Rohani's NPI, 1962898312, was assigned on April 13, 2015. Dr. Rohani graduated from Vanderbilt University School Of Medicine in 2015. Dr. Rohani holds Texas license S6926.

Dr. Rohani's primary practice is Mcguiness Dermatology, at 6000 W Spring Creek Pkwy 200 Mcguiness Dermatology, Plano, TX 75024-3617. The practice phone is (972) 316-4555.

Dr. Rohani's primary practice is Mcguiness Dermatology in Plano, Texas. The medical group on file is McGuiness Dermatology. Dmand AI also links Dr. Rohani to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rohani practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Rohani's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Rohani is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rohani's licenses on file in 3 states: Texas, California and Massachusetts.

Dmand AI lists acne, cancerous skin growth removal, contact dermatitis and skin cyst among the conditions Dr. Rohani treats.

CMS data shows 1,819 Medicare services from Dr. Rohani across 23 procedure codes in 2024, for 528 Medicare patients. Medicare paid $552,179 for them. Every service was in an office.

CMS counts 528 Medicare patients who saw Dr. Rohani in 2024. The largest group is 75 to 84, with 242 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rohani's median patient age at 70, with 41% women.

In 2024, Dr. Rohani wrote 324 Medicare Part D claims for 200 patients. 100% of them were for generic drugs. CMS names the drug for 275 of them, across 5 drugs with 11 or more claims each, at $2,462 in total drug cost. In 2023, CMS named 271 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rohani for performance year 2024, reported as part of a group. Dr. Rohani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rohani as offering telehealth. CMS counts 128 procedures of melanoma (skin cancer) excision by Dr. Rohani, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Rohani, published from 2013 to 2020. 2017 was the busiest year, with 3. The most frequent topics are Mohs Surgery, Skin Neoplasms and Biopsy, Needle. Dr. Rohani's most frequent co-authors are Nadia Yasmin Abidi, MD, Joseph M. Aulino, MD and David Raymond Carr, MD.

CMS Open Payments shows 21 general payments to Dr. Rohani from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Kerecis Limited paid the most, $437.

Dmand AI lists 1 award for Dr. Rohani.

Dr. Rohani graduated from Vanderbilt University School Of Medicine in 2015.

Dr. Rohani is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.